OncXerna Therapeutics to Present at The LifeSci Partners Private Company Summer Symposium
WALTHAM, Mass., July 19, 2021 (GLOBE NEWSWIRE) -- OncXerna Therapeutics, Inc. (“OncXerna”), a precision medicine company using an innovative RNA-expression...
Year: 2021
Passage Bio Announces Key Executive Appointments
Chief Commercial Officer, Chief Financial Officer and Chief Medical Officer to focus on driving company growth and advancing robust pipeline...
Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS’ Co-founder Professor Karl-Göran Tranberg Published in the Journal “Frontiers in Oncology”
IRVINE, Calif., July 19, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal...
Prelude Therapeutics Announces Appointment of Martin Babler to its Board of Directors
WILMINGTON, Del., July 19, 2021 (GLOBE NEWSWIRE) -- Prelude Therapeutics Inc. (Nasdaq: PRLD), a clinical-stage precision oncology company, today announced...
Global WholeHealth Partners Corp (OTC: GWHP), as Mentioned in the S1 Filing of July 2020, has Begun to Drawdown on the up to $100,000,000 in Equity Funding According to the Purchase Agreement with EMC2
Global WholeHealth Partners Corp is now Funded for Growth and Expansion SAN CLEMENTE, CA, July 19, 2021 (GLOBE NEWSWIRE) --...
Tonix Pharmaceuticals Announces New Board Member, Carolyn E. Taylor
NEW YORK, July 19, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix), a clinical-stage biopharmaceutical company, today...
CytoDyn Announces Preliminary Results from 30 mTNBC Patients Treated with Leronlimab. Decreases in CAMLs after 4 Doses of Leronlimab were Identified in Over 70% of Patients and were Associated with a 450% Significant Increase in Overall Survival at 12-Month Analysis
CytoDyn will seek FDA guidance on proceeding with an expedited regulatory plan for approval of leronlimab with existing FDA Fast...
InterSystems Introduces HealthShare Message Transformation Service as Part of the Amazon HealthLake Launch
Cloud-based, on-demand service translates existing healthcare data to comply with HL7® FHIR® standards CAMBRIDGE, Mass.--(BUSINESS WIRE)--InterSystems, a creative data technology...
Masimo Introduces the MX-7™ rainbow SET® Technology Board for Original Equipment Manufacturing Partners
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the release of MX-7™, its latest and most advanced rainbow SET® board. Designed...
Core One Labs to Present on its Proprietary Biosynthetic Psilocybin Technology at Investor Town Hall Event on August 4, 2021
VANCOUVER, British Columbia, July 17, 2021 (GLOBE NEWSWIRE) -- Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6, WKN:...
ECMOHO Announces Strategic Cooperation Agreement with South Korean ChongKunDang Group to Establish Distribution of High-End Health Foods
SHANGHAI, China, July 16, 2021 (GLOBE NEWSWIRE) -- ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions...
Avicanna Announces Change of Auditor
TORONTO, July 16, 2021 (GLOBE NEWSWIRE) -- Avicanna Inc. ("Avicanna" or the "Company") (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a...
Double National Business Award Win for Essentialise Workplace Wellbeing and Lee Chambers
MANCHESTER, UK / ACCESSWIRE / July 16, 2021 / Essentialise Workplace Wellbeing, the Lancashire based health and wellbeing company, have...
NervGen Pharma Grants Stock Options
Vancouver, British Columbia--(Newsfile Corp. - July 16, 2021) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"),...
1933 Industries Announces Extraordinary Meeting of Debentureholders to Delist Convertible Debentures in order to Extend the Maturity Date
VANCOUVER, BC / ACCESSWIRE / July 16, 2021 / 1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE:TGIF)(OTCQB:TGIFF), a Nevada-focused cannabis...
U.S. FDA Grants Full Approval of REZUROCK(TM) (belumosudil) for the Treatment of Patients with Chronic Graft-Versus-Host Disease (cGVHD)
- REZUROCK is approved for the treatment of adult and pediatric patients 12 years and older with cGVHD after failure...
MorphoSys Concludes a US $100 Million Capital Increase to Implement the Purchase of 1,337,552 shares by Royalty Pharma
PLANEGG, GERMANY / ACCESSWIRE / July 16, 2021 / MorphoSys AG (FSE:MOR); (NASDAQ:MOR) ("MorphoSys") today announced that its Management Board,...
Certive Announces New Hospital Client
SCOTTSDALE, AZ and VANCOUVER, BC / ACCESSWIRE / July 16, 2021 / Certive Solutions Inc. (OTCQB:CTVEF)(CSE:CBP) ("Certive" or the "Company")...
Aptevo Therapeutics’ Chief Scientific Officer, Jane Gross, PhD, to Present at Upcoming Cambridge Health Institute PEGS Virtual Conference
SEATTLE, WA / ACCESSWIRE / July 16, 2021 / Aptevo Therapeutics Inc. ("Aptevo") (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing...
Clover Health Announces Grocery Benefit Is Available to Eligible Members in 101 Counties
Participating retailers include CVS, Kroger, Walgreens, and WalmartNASHVILLE, Tenn., July 16, 2021 (GLOBE NEWSWIRE) -- Today, Clover Health (Nasdaq: CLOV)...